Compositions, kits, and methods for diagnosing SARS-CoV-2 using said kits.

By specifically amplifying the SARS-CoV-2 leader sequence and constructing primers for the internal control RNase P gene, the problems of false positives and long detection times in existing technologies have been solved, enabling rapid and accurate diagnosis of SARS-CoV-2 infection.

CN115803463BActive Publication Date: 2026-11-17GENOMICTREE
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202180015768.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2020-03-06
Filing Date
2021-03-05
Publication Date
2026-11-17
Estimated Expiration
2041-03-05

AI Technical Summary

Technical Problem

Existing technologies for diagnosing SARS-CoV-2 infection suffer from false positive amplification and excessively long detection times. In particular, the low abundance of the E gene and RdRP gene in virus-infected cells leads to experimental errors and RNA stability issues.

Method used

We used a nucleic acid oligomer that specifically amplified the SARS-CoV-2 leader sequence and constructed primers for the internal control RNase P gene to prevent false-positive amplification of genomic DNA. This was combined with real-time quantitative PCR technology for rapid detection.

Benefits of technology

It enables rapid and accurate diagnosis of SARS-CoV-2 infection, avoids false positive results, and improves the sensitivity and specificity of detection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115803463B_ABST
    Figure CN115803463B_ABST
Patent Text Reader

Abstract

This invention relates to a composition for diagnosing whether a person has been infected with the novel coronavirus (SARS-CoV-2: Severe Acute Respiratory Syndrome Coronavirus 2), a kit comprising said composition, and a method for diagnosing whether a person has been infected with said novel coronavirus using said kit. Specifically, the invention relates to a composition for diagnosing whether a person has been infected with the novel coronavirus, said composition comprising a nucleic acid oligomer capable of specifically amplifying by targeting a leader sequence most abundantly present in cells infected with said novel coronavirus; a kit comprising said composition; and a method for diagnosing whether a person has been infected with said novel coronavirus using said kit.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to a composition for diagnosing novel coronavirus (SARS-CoV-2: severe acute respiratory syndrome coronavirus 2) infection, a kit comprising said composition, and a method for diagnosing novel coronavirus infection using said kit. More specifically, this invention relates to a composition for diagnosing novel coronavirus infection, said composition comprising a nucleic acid oligomer capable of specifically amplifying a leader sequence present at maximum abundance as a target in cells infected with the novel coronavirus; a kit comprising said composition; and a method for diagnosing novel coronavirus infection using said kit. Background Technology

[0002] Coronaviruses are viruses with a positive-sense single-stranded RNA genome of approximately 27-32 kb in length, and they affect humans and other mammals. Coronaviruses are known to produce genomic RNA and 6-8 subgenomic RNAs with a common mRNA at the 3' end through replication and transcription (Imbert I. et al.; A second, non-canonical RNA-dependent RNA polymerase in SARS Coronavirus. The EMBO Journal. 2006, 25:4933-4942).

[0003] Coronavirus infections present with mild symptoms in most people, but are highly contagious, and in the past 20 years, 10,000 or more people have been infected with SARS coronavirus (Severe Acute Respiratory Syndrome, with a case fatality rate of 10%) and MERS coronavirus (Middle East Respiratory Syndrome, with a case fatality rate of 37%).

[0004] However, the recently discovered novel coronavirus (SARS-CoV-2) infection is an acute respiratory syndrome that presents with symptoms such as fever, cough, shortness of breath, and atypical pneumonia.

[0005] Generally, methods such as SSP-PCR (single-specific primer polymerase chain reaction), real-time PCR, PCR-RFLP (PCR-restriction fragment length polymorphism analysis), and sequencing are used to analyze the viral genome. For the diagnosis of SARS-CoV-2 infection, the coronavirus is first detected by a pan-coronavirus test, and then a combination of real-time PCR and sequencing is used. The problem with this method is that the diagnosis of infection takes 24 hours or longer.

[0006] Recently, the U.S. Centers for Disease Control and Prevention (CDC) and the WHO developed and provided RT-PCR (Reverse Transcription Real-Time PCR) tests to shorten testing time (Real-time RT-PCR Panel for Detection of 2019-Novel Coronavirus). CDC, Respiratory Virology Branch, Viral Diseases Division. The CDC-developed test method amplifies three regions of the N gene, which encodes the nucleocapsid protein of SARS-CoV-2. The WHO-developed method is a one-step real-time PCR capable of simultaneous screening and confirmation, used to screen for the E gene region with high sequence homology to existing SARS-related viruses, and can amplify the RdRP (RNA-dependent RNA polymerase) gene, which can specifically detect SARS-CoV-2 to confirm SARS-CoV-2 infection. Figure 1 ).

[0007] However, since the E gene and RdRP gene are of low abundance in virus-infected cells, there may be cases where they cannot be detected due to experimental errors or depending on the RNA stability of the sample.

[0008] Furthermore, the US Centers for Disease Control and Prevention (CDC) and the WHO use the human RNase P gene as an internal control gene to determine the suitability of RNA samples and have disclosed primer and probe sequences for amplifying RNase P cDNA. However, the inventors of this application have determined that the disclosed primer and probe sequences are primers targeting the interior of the first exon without considering RNA splicing, and therefore false-positive amplification may occur when applied to genomic DNA. When RNA is extracted from the sample at the test site, genomic DNA is usually not completely removed, which may lead to errors in determining sample suitability.

[0009] In light of this technological background, the inventors of this application have developed a novel detection method that targets the most abundant leader sequence in initially infected cells to diagnose SARS-CoV-2 infection. Furthermore, considering RNA splicing, primers for an internal control RNase P gene were constructed to prevent false-positive amplification of genomic DNA.

[0010] The information described in this background section is only intended to enhance understanding of the background of the invention and should not be construed as including information relating to the technology known to those skilled in the art to which this invention pertains. Summary of the Invention

[0011] The purpose of this invention is to address the problems encountered in related technologies and to provide compositions, kits, and diagnostic methods using said kits that can accurately diagnose SARS-CoV-2 infection without producing false positives.

[0012] To achieve the above objectives, the present invention provides a composition for diagnosing coronaviruses, the composition comprising a nucleic acid oligomer capable of specifically amplifying a coronavirus (SARS-CoV-2: severe acute respiratory syndrome coronavirus 2) precursor including the sequence of SEQ ID NO:10.

[0013] In addition, the present invention provides a kit for diagnosing coronaviruses comprising the aforementioned composition.

[0014] In addition, the present invention provides a method for providing information on coronavirus diagnosis, the method comprising treating a sample with a nucleic acid oligomer capable of specifically amplifying a coronavirus (SARS-CoV-2: severe acute respiratory syndrome coronavirus 2) precursor including the sequence of SEQ ID NO:10. Attached Figure Description

[0015] Figure 1 The gene shown is for diagnosing the novel coronavirus according to WHO recommendations;

[0016] Figure 2 The mechanism of expressing coronavirus subgenomic RNA is illustrated;

[0017] Figure 3 The results of detecting SARS-CoV-2 leader RNA sequences by RT-qPCR according to an embodiment of the present invention are shown;

[0018] Figure 4 The results of amplifying the leader sequence from SARS-CoV-2 RNA by RT-qPCR according to an embodiment of the present invention are shown.

[0019] Figure 5a The structure of the RNase P gene and the region amplified by the nucleic acid oligomers of the present invention are shown; and

[0020] Figure 5b The results of RNase P gene amplification by RT-qPCR are shown. Detailed Implementation

[0021] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention pertains. Generally, the nomenclature used herein is well-known and typical in the art.

[0022] The inventors of this application have confirmed that a novel detection method can be used to rapidly and accurately diagnose SARS-CoV-2 infection by targeting a leader sequence present at maximum abundance in initially infected cells.

[0023] One aspect of the present invention relates to a composition for diagnosing coronaviruses, the composition comprising a nucleic acid oligomer capable of specifically amplifying a coronavirus (SARS-CoV-2: severe acute respiratory syndrome coronavirus 2) precursor comprising the sequence of SEQ ID NO:10.

[0024] Additionally, the present invention relates to a method for providing information on coronavirus diagnosis, the method comprising treating a sample with a nucleic acid oligomer capable of specifically amplifying a coronavirus (SARS-CoV-2: severe acute respiratory syndrome coronavirus 2) precursor including the sequence of SEQ ID NO:10.

[0025] Regarding the leader sequence, the genomic RNA and transcribed subgenomic mRNA of coronaviruses share a common leader sequence of approximately 72-77 bp at the 5' end, a unique characteristic of coronaviruses. In the viral sequence, the leader sequence is the target present in maximum abundance in infected cells. This is because all subgenomic RNAs of coronaviruses exhibit leader-linking, meaning that the approximately 72 bp leader sequence (leader RNA) corresponding to the 5' end of the genomic RNA binds to the 5' end of each subgenomic RNA.

[0026] Therefore, in viral genes within cells, the leader sequence has the highest copy number, followed by the copy number of the subgenomic RNA encoding the N protein. Thus, using the leader sequence as a detection target is considered highly effective for detecting coronaviruses present in small quantities in the early stages of infection with milder symptoms.

[0027] In this specification, a nucleic acid oligomer can be a material comprising two or more nucleotides, produced by polymerizing nucleic acids into monomers. Nucleic acid oligomers can be used as primers or probes.

[0028] As used herein, the term "primer" refers to a single-stranded oligonucleotide capable of initiating template-guided DNA synthesis in a buffer solution at a suitable temperature and under appropriate conditions (i.e., four different nucleoside triphosphates and a polymerase). Primers can be constructed to be "substantially" complementary to each strand of the locus to be amplified. This means that, under the conditions used for the polymerization reaction, the primers have sufficient complementarity to hybridize with the corresponding nucleic acid strands.

[0029] In one embodiment, the nucleic acid oligomer capable of specifically amplifying the coronavirus (SARS-CoV-2) precursor including the sequence of SEQ ID NO:10 can be a primer including, for example, the sequence of SEQ ID NO:1 or SEQ ID NO:2.

[0030] For primers, for example, forward and reverse primers can be paired and used simultaneously for PCR. Forward primers that specifically amplify the SARS-CoV-2 leader sequence including the sequence of SEQ ID NO:10 can include, for example, the sequence of SEQ ID NO:1. Reverse primers can include, for example, the sequence of SEQ ID NO:2.

[0031] Furthermore, considering RNA splicing, primers for an internal control RNase P gene were constructed, confirming that false-positive amplification of genomic DNA could be prevented.

[0032] Internal control genes are oligonucleotides used to determine the suitability of RNA samples and are not complementary to the target gene. In one specific embodiment of the invention, the human RNase P gene is used as a routine internal control gene.

[0033] It has been confirmed that the primer and probe sequences published by the CDC for amplifying RNase P cDNA are primers targeting the first exon and do not account for RNA splicing. Therefore, false positive amplification may occur when applied to genomic DNA. When RNA is extracted from the sample at the test site, genomic DNA is usually not completely removed, which may lead to errors in determining sample suitability.

[0034] In one embodiment, it may further include a nucleic acid oligomer capable of specifically amplifying RNase P including the sequence of SEQ ID NO:11.

[0035] The nucleic acid oligomer can be, for example, a primer comprising a sequence including SEQ ID NO:7 or SEQ ID NO:9. It has been confirmed that the primers according to the invention target a sequence complementary to the 5' region of the second exon, and therefore do not result in false-positive amplification when applied to genomic DNA.

[0036] For primers, for example, forward and reverse primers can be paired and used simultaneously for PCR. Forward primers that specifically amplify RNase P including the sequence of SEQ ID NO:11 may include, for example, the sequence of SEQ ID NO:7. Reverse primers may include, for example, the sequence of SEQ ID NO:8.

[0037] In this invention, a probe capable of complementary hybridization with a coronavirus precursor or RNase P product specifically amplified by a nucleic acid oligomer may be included.

[0038] As for probes, they can be oligonucleotides that can hybridize with amplification products under specific conditions.

[0039] In hybridization reactions, the conditions used to achieve a certain level of stringency vary depending on the characteristics of the nucleic acids to be hybridized. For example, when selecting hybridization conditions, the length of the nucleic acid region to be hybridized, the degree of homology, the nucleotide sequence composition (e.g., GC / AT composition ratio), and the nucleic acid type (e.g., RNA or DNA) are considered. Another consideration is whether the nucleic acid is immobilized on, for example, a filter.

[0040] Examples of different stringency conditions are as follows: 2X SSC / 0.1% SDS at room temperature (hybridization conditions), 0.2X SSC / 0.1% SDS at room temperature (low stringency conditions), 0.2X SSC / 0.1% SDS at 42°C (medium stringency conditions), and 0.1X SSC at 68°C (high stringency conditions). The washing process can be performed using any of these conditions (e.g., high stringency conditions), or the conditions can be used in the order described above, each lasting 10 to 15 minutes, and some or all of the above conditions can be repeated. However, as mentioned above, the optimal conditions vary depending on the specific hybridization reaction and can be determined experimentally. Generally, high stringency conditions are used for hybridization of important probes.

[0041] In one implementation, a probe capable of complementary hybridization with an amplified coronavirus precursor may include, for example, the sequence of SEQ ID NO:3.

[0042] In one embodiment, a probe capable of complementary hybridization with the amplified RNase P product used as an internal control may include the sequence of SEQ ID NO:9.

[0043] In some cases, the probe is detectably labeled and may be labeled with, for example, radioisotopes, fluorescent compounds, bioluminescent compounds, chemiluminescent compounds, metal chelates, or enzymes. Appropriate labeling of probes as described above is a technique well known in the art and can be performed using typical methods.

[0044] The amount of amplified product can be detected using fluorescent signals. Intercalation methods using an intercalating agent (which exhibits fluorescence when bound to the double-stranded DNA of the amplified product to which the probe binds) and methods using oligonucleotides in which the 5' end is labeled with a fluorescent material and the 3' end is labeled with a quencher, etc., are possible.

[0045] The amplification according to the invention can be performed by real-time quantitative amplification using reverse transcriptase (e.g., real-time polymerase chain reaction (real-time PCR)), and the amount of PCR amplification product in the real-time polymerase chain reaction can be detected using a fluorescence signal. During the real-time polymerase chain reaction, the intensity of the fluorescence signal increases with the increase of the amount of polynucleotides, and an amplification characteristic curve showing the change of fluorescence signal intensity with the number of amplification cycles is obtained.

[0046] Generally, amplification characteristic curves include: a baseline region, where background fluorescence signals appear that do not reflect the actual amount of polynucleotides; an exponential region, where the fluorescence signal increases with the amount of polynucleotide product; and a plateau region, where there is no increase in fluorescence signal intensity when the PCR reaction reaches saturation.

[0047] Typically, the fluorescence signal intensity at the transition point from the baseline region to the exponential region (specifically, when the amount of PCR amplification product reaches a fluorescence-detectable level) is called the threshold, and the number of amplification cycles corresponding to the threshold in the amplification characteristic curve is called the threshold cycle (Ct) value.

[0048] The concentration of the amplified gene can be confirmed by measuring the Ct value and analyzing the standard curve (where the concentration is determined based on the Ct (threshold cycle) value of the standard material), thus determining the methylation specificity sensitivity and / or specificity.

[0049] In one implementation, the sample may include a wide range of biological fluids obtained from bodily fluids, cell lines, tissue cultures, etc., derived from a suspected patient or subject to diagnosis, and examples may include, but are not limited to, sputum from the lower respiratory tract, oropharyngeal and / or nasopharyngeal swabs from the upper respiratory tract, culture samples, tissue samples, blood, etc.

[0050] This may further include extracting nucleic acids from the sample, and the extraction of nucleic acids may be performed using, for example, any of a variety of commercially available kits or extraction reagents.

[0051] Another aspect of the present invention relates to a kit comprising the said composition.

[0052] In one embodiment, the kit may include a compartmentalized carrier for containing samples, a container including reagents, and a container including nucleic acid oligomers. In some cases, it may further include a container including probes for detecting each gene amplification product.

[0053] The carrier is suitable for accommodating one or more containers, such as bottles and tubes, and each container contains separate components for use in the method of the present invention. In the context of the present invention, the reagents necessary for the containers can be readily dispensed by those skilled in the art.

[0054] The kits according to the invention may optionally include reagents necessary for nucleic acid amplification PCR reactions, such as polymerases, buffers, and deoxyribonucleotide-5-triphosphate. The kits according to the invention may further include various polynucleotide molecules, buffers, and reagents.

[0055] In the kit, the optimal amount of reagents, buffers or reactants used for a particular reaction can be determined by those skilled in the art, and the kit can be manufactured as a separate package or compartment containing each of the primers or probes described above.

[0056] Example

[0057] A better understanding of the present invention can be obtained through the following embodiments. These embodiments are for illustrative purposes only and should not be construed as limiting the scope of the invention, as will be apparent to those skilled in the art.

[0058] Example 1: Design of primers and probes for detecting SARS-CoV-2 and an internal control gene

[0059] Primers and probes for amplifying the leader cDNA sequence (SEQ ID NO:10) of SARS-CoV-2 (GenBank No. MN988668.1: SEQ ID NO:12) and the internal control gene RNase P (SEQ ID NO:11) were designed using the Primer 3 program (http: / / bioinfo.ut.ee / primer3-0.4.0 / ) (Table 1).

[0060] [Table 1] Primer and probe sequences

[0061]

[0062] Example 2: Synthesis of SARS-CoV-2 precursor and RNase P gene RNA

[0063] To synthesize RNA corresponding to the SARS-CoV-2 leader sequence, a 110 bp DNA sequence (SEQ ID NO:13) containing the 72 bp leader sequence of SARS-CoV-2 (SEQ ID NO:10) was synthesized (NeoProbe, South Korea). To synthesize RNA for the RNase P gene (GenBank No. NC_000010.11: SEQ ID NO:14), a 180-bp DNA sequence (SEQ ID NO:2) corresponding to the RNase P sequence was synthesized. RNA was constructed via in vitro transcription by ligating the T7 promoter sequence to the 5' end of each synthesized DNA.

[0064] (1) In vitro transcription (IVT)

[0065] According to the manufacturer's instructions, use MEGAScript. TM The T7 transcription kit (Invitrogen) uses 50 ng of each of the two template PCR products as follows.

[0066] [Table 2]

[0067]

[0068] After 2 hours of reaction, 4 μl of DNase was added to remove residual DNA, and the mixture was incubated at 37°C for 15 minutes. The synthesized precursor and RNase p RNA were purified using the QIAamp RNeasy Mini Kit (Qiagen) according to the manufacturer's instructions. Finally, the synthesized RNA was eluted with 50 μl of RNase-free DW.

[0069] Example 3: Detection of SARS-CoV-2 leader cDNA and RNase P cDNA in real time using reverse transcription polymerase

[0070] RT-qPCR was performed as follows. The reaction solution composition is shown in the table below, and an AB 7500Fast (ThermoFisher, USA) system was used for the RT-qPCR reaction. In the first reverse transcription (RT) step, cDNA complementary to the RNA was synthesized, and in the second real-time PCR (qPCR) step, the cDNA was amplified.

[0071] [Table 3] Composition of RT-qPCR reaction solution

[0072] reagents concentration Volume (uL) RNA sample - 5 <![CDATA[Master mixture * > 4X 5 forward primer 10pmole / uL 1 reverse primer 10pmole / uL 1 probe 5pmole / uL 1 Water without RAXE - 8 total - 20

[0073] *TOPreal One-step RT-qPCR Kit (Enzynomics, South Korea)

[0074] [Table 4] RT-qPCR conditions

[0075]

[0076] (1) Detection results of SARS-CoV-2 leader RNA sequence

[0077] To confirm the detection of cDNA complementary to the SARS-CoV-2 leader RNA sequence, a one-step RT-qPCR was performed using leader RNA (104 copies), leader DNA for in vitro transcription (104 copies), human genomic DNA (10 ng), and total human RNA (10 ng). Figure 3Therefore, amplification was confirmed only in the leader cDNA and leader DNA, and no nonspecific amplification was confirmed in the remaining template (Table 5).

[0078] [Table 5] Detection results of SARS-CoV-2 leader RNA

[0079]

[0080] To confirm the amplification of SARS-CoV-2 leader RNA in practice, RNA isolated from SARS-CoV-2 strains isolated from Korean individuals and stored at the Korean National Pathogen Culture Collection was used. A one-step RT-qPCR was performed in the same manner as described above. Based on the test results, normal amplification of the SARS-CoV-2 leader RNA was confirmed. Figure 4 (and Table 6).

[0081] [Table 6] Detection results of leader RNA from SARS-CoV-2 RNA

[0082] sample <![CDATA[Amplification coefficient (cycle threshold; C T )]]> SARS-CoV-2 RNA (5ng) 18.2 <![CDATA[Leader RNA (10 4 copies)]]> 29.4 Leader DNA 31.3 DW Not detected

[0083] (2) Detection results of RNase p RNA

[0084] The human RNase P gene was used as an internal control gene to determine the suitability of RNA samples. Regarding the primers and probes used to amplify RNase P RNA, despite the sequences published by the US Centers for Disease Control and Prevention, based on the inventors' confirmation, the primers were constructed within the first exon without considering RNA splicing, thus resulting in false-positive amplification of genomic DNA.

[0085] Because genomic DNA is often not completely removed when RNA is extracted from a sample, errors can occur in determining sample suitability. Therefore, to address this issue, the inventors devised a novel reverse primer based on RNA splicing to prevent false-positive amplification of genomic DNA.

[0086] like Figure 5a As shown, the RNaseP gene is a gene consisting of a total sequence of approximately 36.6 kb and a total of 11 exons.

[0087] All primers and probes corresponding to the RNase P gene sequence provided by the US Centers for Disease Control and Prevention were constructed at the region corresponding to the first exon without considering RNA splicing, and false positive amplification occurred when amplifying human genomic DNA. Figure 5b (a)). In contrast, no false-positive amplification of human genomic DNA occurred when the reverse primers developed by the inventors were used. Figure 5b (b) in the middle.

[0088] Therefore, the inventors solved the problem of false-positive amplification of genomic DNA by constructing a reverse primer that is complementary to the 5′ region of the second exon approximately 2.8 kb away. Amplification results based on IVT-generated RNaseP RNA and total human RNA confirmed that normal amplification occurred (Table 7).

[0089] [Table 7] Results of RNase P gene amplification

[0090] sample <![CDATA[Amplification coefficient (cycle threshold; C T )]]> RNase p RNA (10 pg) 14.5 Human total RNA (10 ng) 26.6 DW Not detected

[0091] Example 4: Evaluation of the ability to diagnose SARS-CoV-2 using leader sequences

[0092] To evaluate the diagnostic capability of the leader sequence of SEQ ID NO: 10 for SARS-CoV-2, RNA was extracted from upper respiratory tract samples with known SARS-CoV-2 diagnostic results (180 negative, 76 positive) stored at Lingnan University Medical Center (IRB No. YUMC 2020-07-001) using the QIAampViral RNA Mini Kit (Qiagen, catalog number: 52904 or 52906), according to the manufacturer's protocol. The RNaseP gene was used as an internal control (IC CT values ​​in Table 8).

[0093] To diagnose SARS-CoV-2 infection, RT-qPCR was performed using the method described in Example 3 (Table 8).

[0094] [Table 8] Results of SARS-CoV-2 RT-qPCR using leader sequence

[0095]

[0096]

[0097]

[0098]

[0099]

[0100]

[0101]

[0102] Based on the results of using the leader sequence to diagnose SARS-CoV-2, the sensitivity was confirmed to be 100% (76 / 76) and the specificity to be 100% (180 / 180), which is considered excellent (Table 9). Therefore, the use of the leader sequence to diagnose SARS-CoV-2 is confirmed to be effective.

[0103] [Table 9] Sensitivity and specificity of SARS-CoV detection medical devices using leader sequences

[0104]

[0105] practicality

[0106] According to the present invention, diagnostic results can be obtained in a short time, which makes rapid diagnosis of novel coronavirus infection possible and enables accurate diagnosis by preventing false positives.

[0107] Although specific embodiments of the invention have been disclosed in detail above, it will be apparent to those skilled in the art that the description is merely a preferred exemplary embodiment and should not be construed as limiting the scope of the invention. Therefore, the essential scope of the invention will be defined by the appended claims and their equivalents.

[0108] Sequence List Free Text

[0109] Electronic documents are attached. <110> Genetically Modified Materials Co., Ltd. <120> Compositions, kits, and methods for diagnosing SARS-CoV-2 using said kits. <130> 2576 <160> 14 <170> KoPatentIn 3.0 <210> 1 <211> twenty four <212> DNA <213> Artificial sequence <220> <223> Primers <400> 1 attaaaggtt tataccttcc cagg 24 <210> 2 <211> twenty three <212> DNA <213> Artificial sequence <220> <223> Primers <400> 2 cgtttagaga acagatctac aag 23 <210> 3 <211> 25 <212> DNA <213> Artificial sequence <220> <223> probe <400> 3 taacaaaccaaccaactttcgatct 25 <210> 4 <211> 19 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 4 agatttggac ctgcgagcg 19 <210> 5 <211> 20 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 5 gagcggctgt ctccacaagt 20 <210> 6 <211> twenty three <212> DNA <213> Artificial sequence <220> <223> probe <400> 6 ttctgacctg aaggctctgc gcg 23 <210> 7 <211> 19 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 7 agatttggac ctgcgagcg 19 <210> 8 <211> twenty one <212> DNA <213> Artificial sequence <220> <223> Primers <400> 8 tgatagcaac aactgaatag c 21 <210> 9 <211> twenty three <212> DNA <213> Artificial sequence <220> <223> probe <400> 9 ttctgacctg aaggctctgc gcg 23 <210> 10 <211> 72 <212> DNA <213> Artificial sequence <220> <223> synthetic sequence <400> 10 attaaaggtt tataccttcc caggtaacaa accaaccaac tttcgatctc ttgtagatct 60 gttctctaaa cg 72 <210> 11 <211> 200 <212> DNA <213> Artificial sequence <220> <223> synthetic sequence <400> 11 tgtttgcaga tttggacctg cgagcgggtt ctgacctgaa ggctctgcgc ggacttgtgg 60 agacagccgc tcaccttggc tattcagttg ttgctatcaa tcatatcgtt gactttaagg 120 aaaagaaaca ggaaattgaa aaaccagtag ctgtttctga actcttcaca actttgccaa 180 ttgtacaggg aaaatcaaga 200 <210> 12 <211> 29881 <212> DNA <213]] Artificial sequence <220> <223> SARS-COV-2 synthetic sequence <400> 12 ttaaaggttt ataccttccc aggtaacaaa ccaaccaact ttcgatctct tgtagatctg 60 ttctctaaac gaactttaaa atctgtgtgg ctgtcactcg gctgcatgct tagtgcactc 120 acgcagtata attaataact aattactgtc gttgacagga cacgagtaac tcgtctatct 180 tctgcaggct gcttacggtt tcgtccgtgt tgcagccgat catcagcaca tctaggtttc 240 gtccgggtgt gaccgaaagg taagatggag agccttgtcc ctggtttcaa cgagaaaaca 300 cacgtccaac tcagtttgcc tgttttacag gttcgcgacg tgctcgtacg tggctttgga 360 gactccgtgg aggaggtctt atcagaggca cgtcaacatc ttaaagatgg cacttgtggc 420 ttagtagaag ttgaaaaagg cgttttgcct caacttgaac agccctatgt gttcatcaaa 480 cgttcggatg ctcgaactgc acctcatggt catgttatgg ttgagctggt agcagaactc 540 gaaggcattc agtacggtcg tagtggtgag acacttggtg tccttgtccc tcatgtgggc 600 gaaataccag tggcttaccg caaggttctt cttcgtaaga acggtaataa aggagctggt 660 ggccatagtt acggcgccga tctaaagtca tttgacttag gcgacgagct tggcactgat 720 ccttatgaag attttcaaga aaactggaac actaaacata gcagtggtgt tacccgtgaa 780 ctcatgcgtg agcttaacgg aggggcatac actcgctatg tcgataacaa cttctgtggc 840 cctgatggct accctcttga gtgcattaaa gaccttctag cacgtgctgg taaagcttca 900 tgcactttgt ccgaacaact ggactttatt gacactaaga ggggtgtata ctgctgccgt 960 gaacatgagc atgaaattgc ttggtacacg gaacgttctg aaaagagcta tgaattgcag 1020 acaccttttg aaattaaatt ggcaaagaaa tttgacacct tcaatgggga atgtccaaat 1080 tttgtatttc ccttaaattc cataatcaag actattcaac caagggttga aaagaaaaag 1140 cttgatggct ttatgggtag aattcgatct gtctatccag ttgcgtcacc aaatgaatgc 1200 aaccaaatgt gcctttcaac tctcatgaag tgtgatcatt gtggtgaaac ttcatggcag 1260 acgggcgatt ttgttaaagc cacttgcgaa ttttgtggca ctgagaattt gactaaagaa 1320 ggtgccacta cttgtggtta cttaccccaa aatgctgttg ttaaaattta ttgtccagca 1380 tgtcacaatt cagaagtagg acctgagcat agtcttgccg aataccataa tgaatctggc 1440 ttgaaaacca ttcttcgtaa gggtggtcgc actattgcct ttggaggctg tgtgttctct 1500 tatgttggtt gccataacaa gtgtgcctat tgggttccac gtgctagcgc taacataggt 1560 tgtaaccata caggtgttgt tggagaaggt tccgaaggtc ttaatgacaa ccttcttgaa 1620 atactccaaa aagaaagt caacatcaat attgttggtg actttaaact taatgaag 1680 atcgccatta ttttggcatc tttttctgct tccacaagtg cttttgtgga aactgtgaaa 1740 ggtttggatt ataaagcatt caaaaatt gttgaatcct gtggtaattt taaagttaca 1800 aaaggaaaag ctaaaaaagg tgcctggaat attggtgaac agaaatcaat actgagtcct 1860 ctttatgcat ttgcatcaga ggctgctcgt gttgtacgat caattttctc ccgcactctt 1920 gaaactgctc aaaattctgt gcgtgtttta cagaaggccg ctataacaat actagatgga 1980 atttcacagt attcactgag actcattgat gctatgatgt tcacatctga tttggctact 2040 aacaatctag ttgtaatggc ctacattaca ggtggtgttg ttcagttgac ttcgcagtgg 2100 ctaactaaca tctttggcac tgtttatgaa aaactcaaac ccgtccttga ttggcttgaa 2160 gagaagttta aggaaggtgt agagtttctt agagacggtt gggaaattgt taaatttatc 2220 tcaacctgtg cttgtgaaat tgtcggtgga caaattgtca cctgtgcaaa ggaaattaag 2280 gagagtgttc agacattctt taagcttgta aataaatttt tggctttgtg tgctgactct 2340 atcattattg gtggagctaa acttaaagcc ttgaatttag gtgaaacatt tgtcacgcac 2400 tcaaagggat tgtacagaaa gtgtgttaaa tccagagaag aaactggcct actcatgcct 2460 ctaaaagccc caaaagaaat tatcttctta gagggagaaa cacttcccac agaagtgtta 2520 acagaggaag ttgtcttgaa aactggtgat ttacaaccat tagaacaacc tactagtgaa 2580 gctgttgaag ctccattggt tggtacacca gtttgtatta acgggcttat gttgctcgaa 2640 atcaaagaca cagaaaagta ctgtgccctt gcacctaata tgatggtaac aaacaatacc ttcacactca aaggcggtgc accaacaaag gttacttttg gtgatgacac tgtgatagaa gtgcaaggtt acaagagtgt gaatcact tttgaacttg atgaaaggat tgataaagta cttaatgaga agtgctctgc ctatacagtt gaactcggta cagaagtaaa tgagttcgcc tgtgttgtgg cagatgctgt cataaaaact ttgcaaccag tatctgaat acttacacca ctgggcattg atttagatga gtggagtatg gctacatact acttatttga tgagtctggt gagtttaaat tggcttcaca tatgtattgt tctttctacc ctccagatga ggatgaagaa 3120. 3120. 3120. 3120. 3120. 3120. 3120. 3120. 3120. 3120 gatgattacc aaggtaacc tttggaatt ggtgccactt ctgctgctct tcaacctgaa gaagagcaag aagaagattg gttagatgat gatagtcaac aaactgttgg tcaacaagac ggcagtgagg acaatcagac aactactatt caaacaattg ttgaggttca acctcaatta gagatggac ttacaccagt tgttcagact attgaagtga atagttttag tggttattta aaacttactg acaatgtata cattaaaaat gcagacattg tggaagaagc taaaaggta 3420 aaaccaacag tggttgttaa tgcagccaat gttacctta aacatggagg aggtgttgca 3480 ggagccttaa ataaggctac taacaatgcc atgcaagttg aatctgatga ttacatagct 3540 actaatggac cacttaaagt gggtggtagt tgtgttttaa gcggacacaa tcttgctaaa 3600 cactgtcttc atgttgtcgg cccaaatgtt aacaaaggtg aagacattca acttcttaag 3660 agtgcttatg aaaattttaa tcagcacgaa gttctacttg caccattatt atcagctggt 3720 atttttggtg ctgaccctat acattcttta agagtttgtg tagatactgt tcgcacaaat 3780 gtctacttag ctgtctttga taaaaatctc tatgacaaac ttgtttcaag ctttttggaa 3840 atgaagagtg aaaagcaagt tgaacaaaag atcgctgaga ttcctaaaga ggaagttaag 3900 ccatttataa ctgaaagtaa accttcagtt gaacagagaa aacaagatga taagaaaatc 3960 aaagcttgtg ttgaagaagt tacaacaact ctggaagaaa ctaagttcct cacagaaaac 4020 ttgttacttt atattgacat taatggcaat cttcatccag attctgccac tcttgttagt 4080 gatatgaca tcactttctt aaagaagat gctccatata tagtggtga tgttgttcaa 4140 gagggtgttt taactgctgt ggttatacct actaaaagg ctggtggcac tactgaatg 4200 ctagcgaaag ctttgagaaa agtgccaa gatata accactta cccggggtcag 4260 ggtttaaatg gttacactgt agaggaggca aagacagtgc ttaaaaagtg tAAagtgcc 4320 ttttacattc taccatctat tatctctaat gagaagcaag aaatttctgg aactgttttct 4380 tggaatttgc gagaaatgct tgcacatgca gagaacac gcaattaat gcctgtctgt 4440 gtggaaacta aagccatagt ttcaactata cagcgtaaat ataagggtat taaaataca 4500 gagggtgtgg ttgattatgg tgctagattt tactttaca ccagtaaaac aactgtagcg 4560 tcacttatca acacacttaa cgatctaaat gaactctg ttacaatgcc acttggctat 4620 gtaacacatg gcttaaattt ggaagaagct gctcggtata tgagatctct caagtgcca 4680 gctacagtttt ctgttttctc acctgatgct gttacagcgt ataatggtta tcttacttct 4740 tcttctaaaa cacctgaaga acatttatt gaaaccatct cacttgctgg ttcctataaa 4800 gattggtcct attctggaca atctacacaa ctaggtatag aatttcttaa gagaggtgat 4860 aaaagtgtat attacactag taatcctacc acattccacc tagatggtga agttatcacc 4920 tttgacaatc ttaagacact tctttctttg agaaagtga ggactattaa ggtgtttaca 4980 acatgaca acattaacct ccacacgcaa gttgtggaca tgtcaatgac atatggacaa 5040 cagtttggtc caacttattt ggatggagct gatgttacta aaataaacc tcataattca 5100 catgaaggta aaacatttta tgttttacct aatgatgaca ctctacgtgt tgaggctttt 5160 gagtactacc acaacactga tcctagttt ctgggtaggt acatgtcagc attaaatcac 5220 actaaaaagt ggaataccc acaagttaat ggtttaactt ctattaaatg ggcagataac 5280 aactgttatc ttgccactgc attgttaaca ctccaacaaa tagagttgaa gtttaatcca 5340 cctgctctac aagatgctta ttacagagca agggctggtg aagctgctaa cttttgtgca 5400 cttatcttag cctactgtaa taagacagata ggtgagttag gtgatgttag agaaaatg 5460 agttacttgt ttcaacatgc caatttagat tcttgcaaaa gagtcttgaa cgtggtgtgt 5520 aaaacttgtg vakaacagca vakaaccctt aagggtgtag aagctgttat gtacatgggc 5580 acactttctt atgaacaatt tagaaggt gttcagatac cttgtacgtg tgtaaacaa 5640 gctacaaaat atctagtaca acaggagtca ccttttgtta tgatgtcagc accacctgct 5700 cagtatgaac ttaagcatgg tacatttact tgtgctagtg agtacactgg taattaccag 5760 tgtggtcact aaacatat aacttctaaa gaactttgt attgcataga cggtgcttta 5820 cttacaaagt cctcagaata caaggtcct atttacggatg tttctaca agaaaacagt 5880 tacacaaccia ccataaaacc agttacttat aaattggatg gtgttgtttg tacagaaatt 5940 gaccctaagt tggacaatta ttatagaaa gatatctctt atttcacaga gcaaccatt 6000 gatcttgtac caaccaacc attackcaac gcaagcttcg ataattta gtttgtatgt 6060 gataatca aatttgctga tgatttaac cagttaactg gttatagaa acctgcttca 6120 agagagctta aagttacatt ttccctgac ttaaatggtg atgtggtggc tattgatt 6180 aaacactaca cacccttt taagaagga gctaaattgt tacataacc tattgttgg 6240 catgttaaca atgcaactaa taaagccacg tataaaccaa atacctggtg tatacgttgt 6300 ctttggagca caaaaccagt tgaaacatca aattcgtttg atgtactgaa gtcagaggac 6360 gcgcagggaa tggataatct tgcctgcgaa gatctaaaac cagtctctga agaagtagtg 6420 gaaaatccta catacagaa agacgttctt gagtgtaatg tgaaaactac cgaagttgta 6480 ggagacatta tacttaaacc agcaataat agtttaaaaa ttacagaaga ggttggccac 6540 acagatctaa tggctgctta tgtagacaat tctagtctta ctattaagaa acctaatgaa 6600 ttatctagag tattaggttt gaaaaccctt gctactcatg gtttagctgc tgttaatagt 6660 gtcccttggg atactatagc taattatgct aagccttttc ttaacaaagt tgttagtaca 6720 actactaaca tagttacacg gtgtttaaac cgtgtttgta ctaattatat gccttatttc 6780 tttactttat tgctacaatt gtgtactttt actagaagta caaattctag aattaaagca 6840 tctatgccga ctactatagc aaagaatact gttaagagtg tcggtaaatt ttgtctagag 6900 gcttcattta attatttgaa gtcacctaat ttttctaaac tgataaat tataatttgg 6960 ttttactat taagtgtttg cctaggttct ttaatctact caaccgctgc tttaggtgtt 7020 ttaatgtcta atttaggcat gccttcttac tgtactggtt acagagaagg ctatttgaac 7080 tctactaatg tcactattgc aacctactgt actggttcta taccttgtag tgtttgtctt 7140 agtggtttag attctttaga cacctatcct tctttagaaa ctatacaaat taccatttca 7200 tcttttaaat gggatttaac tgctttggc ttagttgcag agtggtttt ggcatatatt 7260 cttttcacta ggtttttcta tgtacttgga ttggctgcaa tcatgcaatt gttttcagc 7320 tattttgcag tacattttat tagtaattct tggcttatgt ggttaataat taatcttgta 7380 caaatggccc cgatttcagc tatggttaga atgtacatct tctttgcatc attttattat 7440 gtatggaaaa gttatgtgca tgttgtagac ggttgtaatt catcaacttg tatgatgtgt 7500 tacaaacgta atagagcaac aagagtcgaa tgtacaacta ttgttaatgg tgttagaagg 7560 tcctttatg tctatgctaa tggaggtaaa ggcttttgca aactacacaa ttggaattgt 7620 gttaattgtg atacattctg tgctggtagt acatttatta gtgatgaagt tgcgagagac 7680 ttgtcactac agtttaaaag accaataaat cctactgacc agtcttctta catcgttgat 7740 agtgttacag tgaagaatgg ttccatccat ctttactttg ataaagctgg tcaaaagact 7800 tatgaaagac attctctctc tcattttgtt aacttagaca acctgagagc taataacact 7860 aaaggttcat tgcctattaa tgttatagtt tttgatggta aatcaaaatg tgaagaatca 7920 tctgcaaaat cagcgtctgt ttactacagt cagcttatgt gtcaacctat actgttacta 7980 gatcaggcat tagtgtctga tgttggtgat agtgcggaag ttgcagttaa aatgtttgat 8040 gcttacgtta atacgttttc atcaactttt aacgtaccaa tggaaaaact caaaacacta 8100 gttgcaactg cagaagctga acttgcaaag aatgtgtcct tagacaatgt cttatctact 8160 tttatttcag cagctcggca agggtttgtt gattcagatg tagaaactaa agatgttgtt 8220 gaatgtctta aattgtcaca tcaatctgac atagaagtta ctggcgatag ttgtaataac 8280 tatatgctca cctataacaa agttgaaaac atgacacccc gtgaccttgg tgcttgtatt 8340 gactgtagtg cgcgtcatat taatgcgcag gtagcaaaaa gtcacaacat tgctttgata 8400 tggaacgtta aagatttcat gtcattgtct gaacaactac gaaaacaaat acgtagtgct 8460 gctaaaaaga ataacttacc ttttaagttg acatgtgcaa ctactagaca agttgttaat 8520 gttgtaacaa caaagatagc acttaagggt ggtaaaattg ttaataattg gttgaagcag 8580 ttaattaaag ttacacttgt gttccttttt gttgctgcta ttttctattt aataacacct 8640 gttcatgtca tgtctaaaca tactgacttt tcaagtgaaa tcataggata caaggctatt 8700 gatggtggtg tcactcgtga catagcatct acagatactt gttttgctaa caaacatgct 8760 gattttgaca catggtttag ccagcgtggt ggtagttata ctaatgacaa agcttgccca 8820 ttgattgctg cagtcataac aagagaagtg ggttttgtcg tgcctggttt gcctggcacg 8880 atattacgca caactaatgg tgactttttg catttcttac ctagagtttt tagtgcagtt 8940 ggtaacatct gttacacacc atcaaaactt atagagtaca ctgactttgc aacatcagct 9000 tgtgttttgg ctgctgaatg tacaattttt aaagatgctt ctggtaagcc agtaccatat 9060 tgtatgata ccaatgtact agaaggttct gttgcttatg aaagtttacg ccctgacaca 9120 cgtatgtgc tcatggatgg ctctattatt caatttccta acacctacct tgaaggttct 9180 gttagagtgg taacaacttt tgattctgag tactgtaggc acggcacttg tgaaagatca 9240 gaagctggtg tttgtgtatc tactagtggt agatgggtac ttaacaatga ttattacaga 9300 tctttaccag gagttttctg tggtgtagat gctgtaaatt tacttactaa tatgtttaca 9360 ccactaattc aacctattgg tgctttggac atatcagcat ctatagtagc tggtggtatt 9420 gtagctatcg tagtaacatg ccttgcctac tattttatga ggtttagaag agctttttggt 9480 gaatacagtc atgtagttgc cttaatact ttactattcc ttatgtcatt cactgtactc 9540 tgttaacac cagtttactc attcttacct ggtgtttatt ctgttattta cttgtacttg 9600 acattttatc ttactaatga tgtttcttttt ttagcacata ttcagtggat ggttatgttc 9660 acacctttag tacctttctg gataacaatt gcttatatca tttgtatttc cacaaagcat 9720 ttctattggt tctttagtaa ttacctaaag agacgtgtag tctttaatgg tgtttccttt 9780 agtactttg aagaagctgc gctgtgcacc tttttgttaa ataaagaaat gtatctaaag 9840 ttgcgtagtg atgtgctatt acctcttacg caatataata gatacttagc tctttataat 9900 aagtacaagt attttagtgg agcaatggat acaactagct acagagaagc tgcttgttgt 9960 catctcgcaa aggctctcaa tgacttcagt aactcaggtt ctgatgttct ttaccaacca 10020 ccacaaacct ctatcacctc agctgttttg cagagtggtt ttagaaaaat ggcattccca 10080 tctggtaaag ttgagggttg tatggtacaa gtaacttgtg gtacaactac acttaacggt 10140 ctttggcttg atgacgtagt ttactgtcca agacatgtga tctgcacctc tgaagacatg 10200 cttaacccta attatgaaga tttactcatt cgtaagtcta atcataattt cttggtacag 10260 gctggtaatg ttcaactcag ggttattgga cattctatgc aaaattgtgt acttaagctt 10320 aaggttgata cagccaatcc taagacacct aagtataagt ttgttcgcat tcaaccagga 10380 cagacttttt cagtgttagc ttgttacaat ggttcaccat ctggtgttta ccaatgtgct 10440 atgaggccca atttcactat taagggttca ttccttaatg gttcatgtgg tagtgttggt 10500 tttaacatag attatgactg tgtctctttt tgttacatgc accatatgga attaccaact 10560 ggagttcatg ctggcacaga cttagaaggt aacttttatg gaccttttgt tgacaggcaa 10620 acagcacaag cagctggtac ggacacaact attacagtta atgttttagc ttggttgtac 10680 gctgctgtta taaatggaga caggtggttt ctcaatcgat ttaccacaac tcttaatgac 10740 tttaaccttg tggctatgaa gtacaattat gaacctctaa cacaagacca tgttgacata 10800 ctaggacctc tttctgctca aactggaatt gccgttttag atatgtgtgc ttcattaaaa 10860 gaattactgc aaaatggtat gaatggacgt accatattgg gtagtgcttt attagaagat 10920 gaatttacac cttttgatgt tgttagacaa tgctcaggtg ttactttcca aagtgcagtg 10980 aaaagaacaa tcaagggtac acaccactgg ttgttactca caatttttgac ttcactttta 11040 gttttagtcc agagtactca atggtctttg ttcttttttt tgtatgaaaa tgccttttta 11100 ccttttgcta tgggtattat tgctatgtct gcttttgcaa tgatgtttgt caaacataag 11160 catgcatttc tctgtttgtt tttgttacct tctcttgcca ctgtagctta ttttaatatg 11220 gtctatatgc ctgctagttg ggtgatgcgt attatgacat ggttggatat ggttgatact 11280 agtttgtctg gttttaagct aaaagactgt gttatgtatg catcagctgt agtgttacta 11340 atccttatga cagcaagaac tgtgtatgat gatggtgcta ggagagtgtg gacacttatg 11400 aatgtcttga cactcgttta taaagtttat tatggtaatg ctttagatca agccatttcc 11460 atgtgggctc ttataatctc tgttacttct aactactcag gtgtagttac aactgtcatg 11520 tttttggcca gaggtattgt ttttatgtgt gttgagtatt gccctatttt cttcataact 11580 ggtaatacac ttcagtgtat aatgctagtt tattgtttct taggctattt ttgtacttgt 11640 tactttggcc tcttttgttt actcaaccgc tactttagac tgactcttgg tgtttatgat 11700 tacttagttt ctacacagga gtttagatat atgaattcac agggactact cccacccaag 11760 aatagcatag atgccttcaa actcaacatt aaattgttgg gtgttggtgg caaaccttgt 11820 atcaaagtag ccactgtaca gtctaaaatg tcagatgtaa agtgcacatc agtagtctta 11880 ctctcagttt tgcaacaact cagagtagaa tcatcatcta aattgtgggc tcaatgtgtc 11940 cagttacaca atgacattct cttagctaaa gatactactg aagcctttga aaaaatggtt 12000 tcactacttt ctgttttgct ttccatgcag ggtgctgtag acataaacaa gctttgtgaa 12060 gaaatgctgg acaacagggc aaccttacaa gctatagcct cagagtttag ttcccttcca 12120 tcatatgcag cttttgctac tgctcaagaa gcttatgagc aggctgttgc taatggtgat 12180 tctgaagttg ttcttaaaaa gttgaagaag tctttgaatg tggctaaatc tgaatttgac 12240 cgtgatgcag ccatgcaacg taagttggaa aagatggctg atcaagctat gacccaaatg 12300 tataaacagg ctagatctga ggacaagagg gcaaaagtta ctagtgctat gcagacaatg 12360 cttttcacta tgcttagaaa gttggataat gatgcactca acaacattat caacaatgca 12420 agagatggtt gtgttccctt gaacataata cctcttacaa cagcagccaa actaatggtt 12480 gtcataccag actataacac atataaaaat acgtgtgatg gtacaacatt tacttatgca 12540 tcagcattgt gggaaatcca acaggttgta gatgcagata gtaaaattgt tcaacttagt 12600 gaaattagta tggacaattc acctaattta gcatggcctc ttattgtaac agctttaagg 12660 gccaattctg ctgtcaaatt acagaataat gagcttagtc ctgttgcact acgacagatg 12720 tcttgtgctg ccggtactac acaaactgct tgcactgatg acaatgcgtt agcttactac 12780 aacacaacaa agggaggtag gtttgtactt gcactgttat ccgatttaca ggatttgaaa 12840 tgggctagat tccctaagag tgatggaact ggtactatct atacagaact ggaaccacct 12900 tgtaggtttg ttacagacac acctaaaggt cctaaagtga agtatttata ctttattaaa 12960 ggattaaaca acctaaatag aggtatggta cttggtagtt tagctgccac agtacgtcta 13020 caagctggta atgcaacaga agtgcctgcc aattcaactg tattatcttt ctgtgcttt 13080 gctgtagatg ctgctaaagc ttacaaagat tatctagcta gtgggggaca accaatcact 13140 aattgtgtta agatgttgtg tacacacact ggtactggtc aggcaataac agttacaccg 13200 gaagccaata tggatcaaga atcctttggt ggtgcatcgt gttgtctgta ctgccgttgc 13260 cacatagatc atccaaatcc taaaggattt tgtgacttaa aaggtaagta tgtacaaata 13320 cctacaactt gtgctaatga ccctgtgggt tttacactta aaaacacagt ctgtaccgtc 13380 tgcggtatgt ggaaaggtta tggctgtagt tgtgatcaac tccgcgaacc catgcttcag 13440 tcagctgatg cacaatcgtt tttaaacggg tttgcggtgt aagtgcagcc cgtcttacac 13500 cgtgcggcac aggcactagt actgatgtcg tatacagggc ttttgacatc tacaatgata 13560 aagtagctgg ttttgctaaa ttcctaaaaa ctaattgttg tcgcttccaa gaaaaggacg 13620 aagatgacaa tttaattgat tcttactttg tagttaagag acacactttc tctaactacc 13680 aacatgaaga aacaatttat aatttactta aggattgtcc agctgttgct aaacatgact 13740 tctttaagtt tagaatagac ggtgacatgg taccadata atcacgtcaa cgtcttacta 13800 aatacacaat ggcagacctc gtctatgctt taaggcattt tgatgaaggt aattgtgaca 13860 cattaaaaga aatacttgtc acatacaatt gttgtgatga tgattatttc aataaaaagg 13920 actggtatga ttttgtagaa aacccagata tattacgcgt atacgccaac tttaggtgaac 13980 gtgtacgcca agctttgtta aaaacagtac aattctgtga tgccatgcga aatgctggta 14040 ttgttggtgt actgacatta gataatcaag atctcaatgg taactggtat gatttcggtg 14100 atttcataca aaccacgcca ggtagtggag ttcctgttgt agattcttat tattcattgt 14160 taatgcctat attaaccttg accagggctt taactgcaga gtcacatgtt gacactgact 14220 taacaaagcc ttacattaag tgggatttgt taaaatatga cttcacggaa gagaggttaa 14280 aactctttga ccgttatttt aaatattggg atcagacata ccacccaaat tgtgttaact 14340 gtttggatga cagatgcatt ctgcattgtg caaactttaa tgttttattc tctacagtgt 14400 tcccacctac aagttttgga ccactagtga gaaaaatatt tgttgatggt gttccatttg 14460 tagtttcaac tggataccac ttcagagagc taggtgttgt acataatcag gatgtaaact 14520 tacatagctc tagacttagt tttaaggaat tacttgtgta tgctgctgac cctgctatgc 14580 acgctgcttc tggtaatcta ttactagata aacgcactac gtgcttttca gtagctgcac 14640 ttactaacaa tgttgctttt caaactgtca aacccggtaa ttttaacaaa gacttctatg 14700 actttgctgt gtctaagggt ttctttaagg aaggaagttc tgttgaatta aaacacttct 14760 tctttgctca ggatggtaat gctgctatca gcgattatga ctactatcgt tataatctac 14820 caacaatgtg tgatatcaga caactactat ttgtagttga agttgttgat aagtactttg 14880 attgttacga tggtggctgt attaatgcta accaagtcat cgtcaacaac ctagacaaat 14940 cagctggttt tccatttaat aaatggggta aggctagact ttattatgat tcaatgagtt 15000 atgaggatca agatgcactt ttcgcatata caaaacgtaa tgtcatccct actataactc 15060 aaatgaatct taagtatgcc attagtgcaa agaatagagc tcgcaccgta gctggtgtct 15120 ctatctgtag tactatgacc atagacagt ttcatcaaaa attattgaaa tcaatagccg 15180 ccactagagg agctactgta gtaattggaa caagcaaatt ctatggtggt tggcacaaca 15240 tgttaaaaac tgtttatagt gatgtagaaa accctcacct tatgggttgg gattatccta 15300 aatgtgatag agccatgcct aacatgctta gaattatggc ctcacttgtt cttgctcgca 15360 aacatacaac gtgttgtagc ttgtcacacc gtttctatag attagctaat gagtgtgctc 15420 aagtattgag tgaaatggtc atgtgtggcg gttcactata tgttaaacca ggtggaacct 15480 catcaggaga tgccacaact gcttatgcta atagtgtttt taacatttgt caagctgtca 15540 cggccaatgt taatgcactt ttatctactg atggtaacaa aattgccgat aagtatgtcc 15600 gcaatttaca acacagactt tatgagtgtc tctatagaaa tagagatgtt gacacagact 15660 ttgtgaatga gttttacgca tatttgcgta aacatttctc aatgatgata ctctctgacg 15720 atgctgttgt gtgtttcaat agcactttatg catctcaagg tctagtggct agcataaaga 15780 actttaagtc agttctttat tatcaaaaca atgtttttat gtctgaagca aaatgttgga 15840 ctgagactga ccttactaaa ggacctcatg aattttgctc tcaacataca atgctagtta 15900 aacagggtga tgattatgtg taccttcctt acccagatcc atcaagaatc ctaggggccg 15960 gctgttttgt agatgatatc gtaaaaaacag atggtacact tatgattgaa cggttcgtgt 16020 ctttagctat agatgcttac ccacttacta aacatcctaa tcaggagtat gctgatgtct 16080 ttcatttgta cttacaatac ataagaaagc tacatgatga gttaacagga cacatgttag 16140 acatgtattc tgttatgctt actaatgata acacttcaag gtattgggaa cctgagtttt 16200 atgaggctat gtacacaccg catacagtct tacaggctgt tggggcttgt gttctttgca 16260 attcacagac ttcattaaga tgtggtgctt gcatacgtag accattctta tgttgtaaat 16320 gctgttacga ccatgtcata tcaacatcac ataaattagt cttgtctgtt aatccgtatg 16380 tttgcaatgc tccaggttgt gatgtcacag atgtgactca actttactta ggaggtatga 16440 gctattattg taaatcacat aaaccaccca ttagttttcc attgtgtgct aatggacaag 16500 ttttggtttt atataaaaat acatgtgttg gtagcgataa tgttactgac tttaatgcaa 16560 ttgcaacatg tgactggaca aatgctggtg attacatttt agctaacacc tgtactgaaa 16620 gactcaagct ttttgcagca gaaacgctca aagctactga ggagacattt aaactgtctt 16680 atggtattgc tactgtacgt gaagtgctgt ctgacagaga attacatctt tcatgggaag 16740 ttggtaaacc tagacacca cttaaccgaa attatgtctt tactggttat cgtgtaacta 16800 aaaacagtaa agtacaaata ggagagtaca cctttgaaaa aggtgactat ggtgatgctg 16860 ttgtttaccg aggtacaaca acttacaaat taaatgttgg tgattatttt gtgctgacat 16920 cactagtgcc aaatgccatta agtgcaccta cactagtgcc acaagagcac tatgttagaa 16980 ttactggctt atacccaaca ctcaatatct cagatgagtt ttctagcaat gttgcaaatt 17040 atcaaaaggt tggtatgcaa aagtattcta cactccaggg accacctggt actggtaaga 17100 gtcattttgc tattggccta gctctctact acccttctgc tcgcatagtg tatacagctt 17160 gctctcatgc cgctgttgat gcactatgtg agaaggcatt aaaatatttg cctatagata 17220 aatgtagtag aattatacct gcacgtgctc gtgtagagtg ttttgataaa ttcaaagtga 17280 attcaacatt agaacagtat gtcttttgta ctgtaaatgc attgcctgag acgacagcag 17340 atatagttgt ctttgatgaa atttcaatgg ccacaaatta tgatttgagt gttgtcaatg 17400 ccagattacg tgctaagcac tatgtgtaca ttggcgaccc tgctcaatta cctgcaccac 17460 gcacattgct aactaagggc acactagaac cagaatatttt caatcagtg tgtagactta 17520 tgaaaactat agtccagac atgttcctcg gaacttgtcg gcgttgtcct gctgaaattg 17580 ttgacactgt gagtgctttg gtttatgata ataagcttaa agcacataaa ɣaatcag 17640 ctcaatgctt taaaatgttt tataagggtg ttcaccca tgatgttca tctgcaatta 17700 acaggccaca ataggcgtg gtaagagaat tccttacacg taaccctgct tggagaaag 17760 ctgtctttat ttcaccttat aattcacaga atgctgtagc ctcaaagatt ttgggactac 17820 caaccaaac tgttgattca tcacaggggct cagaatatga ctatgtcata ttcactcaa 17880 ccactgaaac agctcactct tgtaatgtaa acgatttaa tgttgctatt accagagcaa 17940 aagtaggcat actttgcata atgtctgata gagaccttta tgacaagttg caatttacaa 18000 gtcttgaaat tccacgtagg atgtggcaa ctttacaagc tgaaatgta acaggactct 18060 ttaaagattg tagtaggta atcactgggt tacatctac acaggcacct acacacctca 18120 gtgttgacac taaattcaaa actgaaggtt tatgtgttga catacctggc atacctaagg 18180 acatgaccta tagaagactc atctctatga tgggttttaa aatgaattat caagttaatg 18240 gttaccctaa catgtttatc acccgcgaag aagctataag acatgtacgt gcatggattg 18300 gcttcgatgt cgaggggtgt catgctacta gagaagctgt tggtaccaat ttacctttac 18360 agctaggttt ttctacaggt gttaacctag ttgctgtacc tacaggttat gttgatacac 18420 ctaataatac agatttttcc agagttagtg ctaaaccacc gcctggagat caatttaaac 18480 acctcatacc acttatgtac aaaggacttc cttggaatgt agtgcgtata aagattgtac 18540 aaatgttaag tgacacactt aaaaatctct ctgacagagt cgtatttgtc ttatgggcac 18600 atggctttga gttgacatct atgaagtatt ttgtgaaaat aggacctgag cgcacctgtt 18660 gtctatgtga tagacgtgcc acatgctttt ccactgcttc agacacttat gcctgttggc 18720 atcattctat tggatttgat tacgtctata atccgtttat gattgatgtt caacaatggg 18780 gttttacagg taacctacaa agcaaccatg atctgtattg tcaagtccat ggtaatgcac 18840 atgtagctag ttgtgatgca atcatgacta ggtgtctagc tgtccacgag tgctttgtta 18900 agcgtgttga ctggactatt gaatatccta taattggtga tgaactgaag attaatgcgg 18960 cttgtagaaa ggttcaacac atggttgtta aagctgcatt attagcagac aaattcccag 19020 ttcttcacga cattggtaac cctaaagcta ttaagtgtgt acctcaagct gatgtagaat 19080 ggaagttcta tgatgcacag ccttgtagtg acaaagctta taaatagaa gaattattct 19140 attcttatgc cacacattct gacaaattca cagatggtgt atgcctattt tggaattgca 19200 atgtcgatag atacctgct aattccattg tttgtagatt tgacactaga gtgctatcta 19260 accttaactt gcctggttgt gatggtggca gtttgtatgt aaataaacat gcattccaca 19320 caccagcttt tgataaaagt gcttttgtta attaaaaca attaccattt ttctattact 19380 ctgacagtcc atgtgagtct catggaaaac aagtagtgtc agatatagat tatgtaccac 19440 taaagtctgc tacgtgtata acacgttgca atttaggtgg tgctgtctgt agacatcatg 19500 ctaatgagta cagattgtat ctcgatgctt atacatgat gatctcagct ggctttagct 19560 tgtgggttta siacaattt gatacttata acctctggaa cactttaca agacttcaga 19620 gtttagaaaa tgtggctttt aatgttgtaa atagggaca ctttgatgga cacaggggtg 19680 aagtaccagt ttcatcatt aaacactg ttcacaaa agttgatggt gttgatgtag 19740 aattgtttga aaaaaaca acattaccctg ttaatgtagc atttgagctt tggctaagc 19800 gcaacattaa accagtacca gaggtgaaaa tactcaataa ttgggtgtg gatatgctg 19860 ctaatactgt gatctgggac tacaaagag atgctccagc acatatactct actattggtg 19920 tttgttctat gactgacata gccagaac accactgaac gatttgtgca caccactg 19980 tctttttga tggtagagtt gatggtcaag tagacttatt tagaaatgcc cgtaatggtg 20040 ttcttattac agaaggtagt gttaaaggtt tacaaccatc tgtaggtccc aaacaagcta 20100 gtcttaatgg agtcacatta attggagag ccgtaaaac acagttcaat tattataga 20160 aagttgatgg tgttgtccaa cattacctg aaacttactt tactcagt agaatttac 20220 aagaatttaa acccaggagt caaatggaaa ttgatttctt agaattagct atggatgaat 20280 tcattgaacg gtataaatta gaaggctatg ccttcgaaca tatcgtttat ggagattta 20340 gtcatagtca gttaggtggt ttacatctac tgattggact agctaaacgt tttaaggaat 20400 caccttttga attagaagat tttattccta tggacagtac agttaaaaac tatttcataa 20460 cagatgcgca aacaggttca tctaagtgtg tgtgttctgt tattgattta ttacttgatg 20520 attttgttga aataataaaa tcccaagatt tatctgtagt ttctaaggtt gtcaaagtga 20580 ctattgacta tacagaaatt tcatttatgc tttggtgtaa agatggccat gtagaaacat 20640 tttacccaaa attacaatct agtcaagcgt ggcaaccggg tgttgctatg cctaatcttt 20700 acaaaatgca aagaatgcta ttagaaaagt gtgaccttca aaattatggt gatagtgcaa 20760 cattacctaa aggcataatg atgaatgtcg caaaatatac tcaactgtgt caatatttaa 20820 acacattaac attagctgta ccctataata tgagagttat acattttggt gctggttctg 20880 ataaaggagt tgcaccaggt acagctgttt taagacagtg gttgcctacg ggtacgctgc 20940 ttgtcgattc agatcttaat gactttgtct ctgatgcaga ttcaactttg attggtgatt 21000 gtgcaactgt acatacagct aataaatggg atctcattat tagtgatatg tacgacccta 21060 agactaaaaaa tgttacaaaa gaaaatgact ctaaagaggg ttttttcact tacatttgtg 21120 ggtttataca acaaaagcta gctcttggag gttccgtggc tataaagata acagaacatt 21180 cttggaatgc tgatctttat aagctcatgg gacacttgc atggtggaca gcctttgtta 21240 ctaatgtgaa tgcgtcatca tctgaagcat ttttaattgg atgtaattat cttggcaaac 21300 cacgcgaaca aatagatggt tatgtcatgc atgcaaatta catattttgg aggaatacaa 21360 atccaattca gttgtcttcc tattctttat ttgacatgag taaatttccc cttaaattaa 21420 ggggtactgc tgttatgtct ttaaaagaag gtcaaatcaa tgatatgatt ttatctcttc 21480 ttagtaaagg tagacttata attagagaaa acaacagagt tgttatttct agtgatgttc 21540 ttgttaacaa ctaaacgaac aatgtttgtt tttcttgttt tattgccact agtctctagt 21600 cagtgtgtta atcttacaac cagaactcaa ttaccccctg catacactaa ttctttcaca 21660 cgtggtgttt attaccctga caaagttttc agatcctcag ttttacattc aactcaggac 21720 ttgttcttac ctttctttc caatgttact tggttccatg ctatacatgt ctctgggacc 21780 aatggtacta agaggtttga taaccctgtc ctaccattta atgatggtgt ttattttgct 21840 tccactgaga agtctaacat aataagaggc tggatttttg gtactacttt agattcgaag 21900 acccagtccc tacttattgt tataacgct actaatgttg ttattaaagt ctgtgaattt 21960 caattttgta atgatccatt tttgggtgtt tattaccaca aaaacaacaa aagttggatg 22020 gaaagtgagt tcagagttta ttctagtgcg aataattgca cttttgaata tgtctctcag 22080 ccttttctta tggaccttga aggaaaacag ggtaatttca aaaatcttag ggaatttgtg 22140 tttaagaata ttgatggtta ttttaaaata tattctaagc acacgcctat taatttagtg 22200 cgtgatctcc ctcagggttt ttcggcttta gaaccattgg tagatttgcc aataggtatt 22260 aacatcacta ggtttcaaac tttacttgct ttacatagaa gttatttgac tcctggtgat 22320 tcttcttcag gttggacagc tggtgctgca gcttattatg tgggtatct tcaacctagg 22380 acttttctat taaataataa tgaaaatgga accattacag atgctgtaga ctgtgcactt 22440 gaccctctct cagaaacaaa gtgtacgttg aaatccttca ctgtagaaaa aggaatctat 22500 caaacttcta actttagagt caaccaaca gaatctattg ttagatttcc tatattaca 22560 aacttgtgcc cttttggtga agttttaac gccaccagat ttgcatctgt ttatgcttgg 22620 aacaggaaga gaatcagcaa ctgtgttgct gattattctg tcctatataa ttccgcatca 22680 ttttccactt ttaagtgtta tggagtgtct cctactaaat taaatgatct ctgctttact 22740 aatgtctatg cagattcatt tgtaattaga ggtgatgaag tcagacaaat cgctccaggg 22800 caaactggaa agattgctga ttataattat aaattaccag atgattttac aggctgcgtt 22860 atagcttgga attctaacaa tcttgattct aaggttggtg gtaattataa ttacctgtat 22920 agattgttta ggaagtctaa tctcaaacct tttgagagag atatttcaac tgaaatctat 22980 caggccggta gcacaccttg taatggtgtt gaaggtttta attgttactt tcctttacaa tcatatggtt tccaacccac taatggtgtt ggttaccaac catacagagt agtagtactt 23160. tcttttgac ttctacatgc accagcaact gtttgtggac ctaaaaagtc tactaatttg gttaaaaca aatgtgtcaa tttcaacttc aatggtttaa caggcacagg tgttcttact gagtctaaca aaaagtttct gcctttccaa caatttggca gagacattgc tgacactact gatgctgtcc gtgatccaca gacacttgag attcttgaca ttacaccatg ttcttttggt ggtgtcagtg ttataacacc aggaacaaat acttctaacc aggttgctgt tctttatcag 23460. gatgttaact gcacagaagt ccctgttgct attcatgcag atcaacttac tcctacttgg cgtgtttatt ctacaggttc taatgttttt caaacacgtg caggctgttt aataggggct gaacatgtca acaactcata tgagtgtgac atacccattg gtgcaggtat atgcgctagt tatcagactc agactaattc tcctcggcgg gcacgtagtg tagctagtca atccatcatt gcctacacta tgtcacttgg tgcagaaaat tcagttgctt acctaataa ctctattgcc 23700 atacccacaa attttactat tagtgttacc acagaaattc taccagtgtc tatgaccaag 23760 acatcagtag attgtacaat gtacatttgt ggtgattcaa ctgaatgcag caatctttg 23820 ttgcaatg gcagttttg tacacaatta aaccgtgctt taactggaat agctgttgaa 23880 caagacaaaa acacccaa agtttttgca caagtcaac aaatttaca aacaccacca 23940 attaagatt ttggtggtt taatttttca caatattac cagatccatc aaaaccaagc 24000 aagaggtcat ttattgaga tctacttttc aacaaagtga cacttgcaga tgctggcttc 24060 atcaacaat atggtgattg ccttggtgat attgctgcta gagacctcat ttgtgcacaa 24120 aagtttaacg gccttactgt ttgccacct tgctcacag atgaatgat tgctcaatac 24180 acttctgcac tgttagcgg tacaatcact tctgttgga ccttgtgc aggtgctgca 24240 ttacaatac cattgctat gcaatggct tataggtttta atggtattgg agttacacag 24300 aatgttctct atgagaacca aaaattgatt gccaaccaat ttaatagtgc tattggcaaa 24360 attcaagact cactttcttc cacagcaagt gcacttggaa aacttcaaga tgtggtcaac 24420 caaaatgcac aagctttaaa cacgcttgtt aaacaactta gctccaattt tggtgcaatt 24480 tcaagtgttt taaatgatat cctttcacgt cttgacaaag ttgaggctga agtgcaaatt 24540 gataggttga tcacaggcag acttcaaagt ttgcagacat atgtgactca acaattaatt 24600 agagctgcag aaatcagagc ttctgctaat cttgctgcta ctaaaatgtc agagtgtgta 24660 cttggacaat caaaaagagt tgatttttgt ggaaagggct atcatcttat gtccttccct 24720 cagtcagcac ctcatggtgt agtcttcttg catgtgactt atgtccctgc acaagaaaag 24780 aacttcacaa ctgctcctgc catttgtcat gatggaaaag cacactttcc tcgtgaaggt 24840 gtctttgttt caaatggcac acactggttt gtaacacaaa ggaattttta tgaaccacaa 24900 atcattacta cagacaacac atttgtgtct ggtaactgtg atgttgtaat aggaattgtc 24960 aacaacacag tttatgatcc tttgcaacct gattagact cattcaagga ggagttagat 25020 aaatatttta agaatcatac atcaccagat gttgatttag gtgacatctc tggcattaat 25080 gcttcagttg taaacattca aaaagaaatt gaccgcctca atgaggttgc caagaattta 25140 aatgaatctc tcatcgatct ccaagaactt ggaagttg agcagtatat aaaatggcca 25200 tggtacattt ggctaggttt tatagctggc ttgattgcca tagtaatggt gacaattatg 25260 ctttgctgta tgaccagttg ctgtagttgt ctcaagggct gttgttcttg tggatcctgc 25320 tgcaaatttg atgaagacga ctctgagcca gtgctcaaag gagtcaaatt acattacaca 25380 25440 aaggtgaaat caaggatgct actccttcag attttgttcg cgctactgca acgataccga 25500 tacaagcctc actccctttc ggatggctta ttgttggcgt tgcacttctt gctgtttttc 25560 agagcgcttc caaaatcata accctcaaaa agagatggca actagcactc tccaagggtg 25620 ttcactttgt ttgcaacttg ctgttgttgt ttgtaacagt ttactcacac cttttgctcg 25680 ttgctgctgg ccttgaagcc ccttttctct atctttatgc tttagtctac ttcttgcaga 25740 gtataaactt tgtaagaata ataatgaggc tttggctttg ctggaaatgc cgttccaaaa 25800 acccattact ttatgatgcc aactattttc tttgctggca tactaattgt tacgactatt 25860 gtatacctta caatagtgta acttcttcaa ttgtcattac ttcaggtgat ggcacaacaa 25920 gtcctatttc tgaacatgac taccagattg gtggttatac tgaaaaatgg gaatctggag 25980 taaaagactg tgttgtatta cacagttact tcacttcaga ctattaccag ctgtactcaa 26040 ctcaattgag tacagacact ggtgttgaac atgttacctt cttcatctac aataaaattg 26100 ttgatgagcc tgaagaacat gtccaaattc acacaatcga cggttcatcc ggagttgtta 26160 atccagtaat ggaaccaatt tatgatgaac cgacgacgac tactagcgtg cctttgtaag 26220 cacaagctga tgagtacgaa cttatgtact cattcgtttc ggaagagaca ggtacgttaa 26280 tagttaatag cgtacttctt tttcttgctt tcgtggtatt cttgctagtt acactagcca 26340 tccttactgc gcttcgattg tgtgcgtact gctgcaatat tgttaacgtg agtcttgtaa 26400 aaccttcttt ttacgtttac tctcgtgtta aaaatctgaa ttcttctaga gttcctgatc 26460 ttctggtcta aacgaactaa atattatatt agtttttctg tttggaactt taattttagc 26520 catggcagat tccaacggta ctattaccgt tgaagagctt aaaaagctcc ttgaacaatg 26580 gaacctagta ataggtttcc tattccttac atggatttgt cttctacaat ttgcctatgc 26640 caacaggaat aggtttttgt atataattaa gttaattttc ctctggctgt tatggccagt 26700 aactttagct tgttttgtgc ttgctgctgt ttacagaata aattggatca ccggtggaat 26760 tgctatcgca atggcttgtc ttgtaggctt gatgtggctc agctacttca ttgcttcttt 26820 cagactgttt gcgcgtacgc gttccatgtg gtcattcaat ccagaaacta acattcttct 26880 caacgtgcca ctccatggca ctattctgac cagaccgctt ctagaaagtg aactcgtaat 26940 cggagctgtg atccttcgtg gacatcttcg tattgctgga caccatctag gacgctgtga 27000 catcaaggac ctgcctaaag aaatcactgt tgctacatca cgaacgcttt cttattacaa 27060 attgggagct tcgcagcgtg tagcaggtga ctcaggtttt gctgcataca gtcgctacag 27120 gattggcaac tataaattaa accagacca ttccagtagc agtgacaata tgctttgct 27180 tgtacagtaa gtgacacag atgtttcatc tcgttgactt tcaggttact atgcagaga 27240 tattactaat tattatgagg acttttaaag ttccattg gatcttgat tacatcataa 27300 acctcataat taaaaattta tctaagtcac taactgagaa taatattct cattagatg 27360 aagagcaacc aatggagat gattaacga acatgaaat tattctttc ttggcactga 27420 taacactcgc tacttgtgag ctttatcact accagagtg tgttagaggt acacagtac 27480 ttttaaaga accttgctct tctggaacat acgagggcaa ttcaccattt catcctctag 27540 ctgataacaa atttgcactg acttgcttta gcactcatt tgctttgct tgtcctgacg 27600 gcgtaaaaca cgtctatcag ttacgtgcca gatcagtttc acctaactg ttcatcagac 27660 aagaggaagt tcaagaactt tactctccaa tttcttat tgttgcggca atagtgttta 27720 taacacttg cttcacactc aaagaaaga cagaatgatt gaacttcat taattgactt 27780 ctatttgtgc tttttagcct ttctgctatt ccttgtttta attatgctta ttatcttttg 27840 gttctcactt gaactgcaag atcataatga aacttgtcac gcctaaacga acatgaaatt 27900 tcttgttttc ttaggaatca tcacaactgt agctgcattt caccaagaat gtagtttaca 27960 gtcatgtact caacatcaac catatgtagt tgatgacccg tgtcctattc acttctattc 28020 taaatggtat attagagtag gagctagaaa atcagcacct ttaattgaat tgtgcgtgga 28080 tgaggctggt tctaaatcac ccattcagta catcgatatc ggtaattata cagtttcctg 28140 tttacctttt acaattaatt gccaggaacc taaattgggt agtcttgtag tgcgttgttc 28200 gttctatgaa gactttttag agtatcatga cgttcgtgtt gttttagatt tcatctaaac 28260 gaacaaacta aaatgtctga taatggaccc caaaatcagc gaaatgcacc ccgcattacg 28320 tttggtggac cctcagattc aactggcagt aaccagaatg gagaacgcag tggggcgcga 28380 tcaaaacaac gtcggcccca aggttaccc aataatactg cgtcttggtt caccgctctc 28440 actcaacatg gcaaggaaga cttaaattc cctcgaggac aaggcgttcc aattaacacc 28500 aatagcagtc cagatgacca aattggctac taccgaagag ctaccagacg aattcgtggt 28560 ggtgacggta aaatgaaaga tctcagtcca agatggtatt tctactacct aggaactggg 28620 ccagaagctg gacttcccta tggtgctaac aaagacggca tcatatgggt tgcaactgag 28680 ggagccttga atacaccaaa agatcacatt ggcacccgca atcctgctaa caatgctgca 28740 atcgtgctac aacttcctca aggaacaaca ttgccaaaag gcttctacgc agaagggagc 28800 agaggcggca gtcaagcctc ttctcgttcc tcatcacgta gtcgcaacag ttcaagaaat 28860 tcaactccag gcagcagtag gggaacttct cctgctagaa tggctggcaa tggcggtgat 28920 gctgctcttg ctttgctgct gcttgacaga ttgaaccagc ttgagagcaa aatgtctggt 28980 aaaggccaac aacaacaagg ccaaactgtc actaagaaat ctgctgctga ggcttctaag 29040 aagcctcggc aaaaacgtac tgccactaaa gcatacaatg taacacaagc tttcggcaga 29100 cgtggtccag aacaaaccca aggaaatttt ggggaccagg aactaatcag acaaggaact 29160 gattacaaac attggccgca aattgcacaa ttgccccca gcgcttcagc gttcttcgga 29220 atgtcgcgca ttggcatgga agtcacacct tcgggaacgt ggttgaccta cacaggtgcc 29280 atcaattgg atgacaaga tccaatttc aagatcaag tcattttgct gaataagcat 29340 attgacgcat acaaacatt cccaccaca gagcctaaaa aggacaaaa gagaaggct 29400 gatgaaactc aagccttacc gcagagacag aagaacagc aaactgtgac tcttctctcct 29460 gctgcagatt tggattt ctccaaacaa ttgcaacaat ccatgagcag tgctgactca 29520 actcaggcct aactcatgc agaccacaca aggcagatgg gctatataa cgttttcgct 29580 tttccgttta cgatatatag tctactcttg tgcagaatga attctcgtaa ctacatagca 29640 caagtagatg tagtaactt tatcacaca tagtactt gtacattag 29700 ggaggacttg aaagagccac cacatttca ccgaggccac gcggagtacg atcgagtgta 29760 cagtgaacaa tgctagggag agctgcctat atggagagc cctaatgtgt aaaatttatt 29820 ttagtagtgc tatccccatg tgatttaat agctcttag gagaatgaca aaaaaaaaaa 29880 a 29881 <210> 13 <211> 110 <212> DNA <213> Artificial sequence <220> <223> Leader synthesis sequence <400> 13 attaaaggtt tataccttcc caggtaacaa accaaccaac tttcgatctc ttgtagatct 60 gttctctaaa cgaactttaa aatctgtgtg gctgtcactc ggctgcatgc 110 <210> 14 <211> 4251 <212> DNA <213> Artificial sequence <220> <223> RNase P synthesis sequence <400> 14 atgggacttc agcatggcgg tgtttgcaga tttggacctg cgagcgggtt ctgacctgaa 60 ggctctgcgc ggacttgtgg agacagccgc tcaccttggc tattcagttg ttgctatcaa 120 tcatatcgtt gactttaagg aaaagaaaca ggaaattgaa aaaccagtag ctgtttctga 180 actcttcaca actttgccaa ttgtacaggg aaaatcaaga ccaattaaaa ttttaactag 240 attaacaatt attgtctcgg atccatctca ctgcaatgtt ttgagagcaa cttcttcaag 300 ggcccggctc tatgatgttg ttgcagtttt tccaaagaca gaaaagcttt ttcatattgc 360 ttgcacacat ttagatgtgg atttagtctg cataactgta acagagaaac taccatttta 420 cttcaaaaga cctcctatta atgtggcgat tgaccgaggc ctggcttttg aacttgtcta 480 tagccctgct atcaaagact ccacaatgag aaggtataca atttccagtg ccctcaattt 540 gatgcaaatc tgcaaaggaa agaatgtaat tatatctagt gctgcagaaa ggcctttaga 600 aataagaggg ccatatgacg tggcaaatct aggcttgctg tttgggctct ctgaaagtga 660 cgccaaggct gcggtgtcca ccaactgccg agcagcgctt ctccatggag aaactagaaa 720 aactgctttt ggaattatct ctacagtgaa gaaacctcgg ccatcagaag gagatgaaga 780 ttgtcttcca gcttccaaga aagccaagtg gtctcactct gtcacccagg ctggagtgca 840 gtggcacaat ctcggctcac tgcaaccttt gcctcttggg ctcaagccat cctcccacct 900 cagcctccca agaactagaa ttcaacaaag acaacttttg atctctcatc agagagatca 960 tactcccaag aacaggcttt gacccttctt taaaagagga ttgtcctggg ctgatgagag 1020 tcactttacc tgaagatacc tgggaagttt tgtctcctct gaggttggcc catggccagt 1080 gactgatgca ggacattaca gcctggccca ctggcctcgg tggtacaatt tatgctcctg 1140 agcaccccat gggattacgc tgtgtgtgga tttctcctga aaccacatat ttgcctcttc 1200 tgccctgttc tgttttttct cattccctta tagaggactc tcagtaagtc acttacacaa 1260 gaatcctaat ttgaaatgct gcttccagga gacctgactt agaaaattgg acaaataaag 1320 ttgatttttt taaatgtcca gtaacatgaa gatgctgaac tttcctagtc atttaggggg 1380 aaatcaccac aaatatatct ggctgatcag gttgaaagtt aaaagaaaaa aagatttata 1440 aagtgggtat tttcaagatg gtgtggaggg agatacaatt tgatgcaagt cttatacttt 1500 tgatgtcaat ttattcttca gaaataactg gttaattata aagggtggat ggataaggat 1560 attcactgca aaatgtctt aaatgtgaaa atggaaacaa cctaaatacc caataataac 1620 aggattaaat aattcattgt acattaaaag aatactgtct ataaagatgt ctagaataag 1680 ttgttcagtt gaagttgtaa agctaaatac acaataccca taatgtgcac agaataataatc 1740 agaatgtcat gaaaccagga ttattggtga tgtgttgctt cctttgttac tcatttctgt 1800 attggcataa tgagtattgg gtgttcaaga ggaggggga ggaagtatga cagatgttat 1860 ggggaaaag caagtachaa caggaca ccttggggga actaataga tctaggact 1920 caggatggc ttcctggagg aaatacagct agaacaagg gggaatga gaagtgatgt 1980 gatggcgtgg agtgggctgt agtgggaaga agagtcttcc agggagctgg cacagtatgt 2040 gaaaacagta aagcaagtgc ctggatttt taaggactg aaatttagt tgagttgaaa 2100 tttagagtttt ggctaggaag gttatgagag atagataa agagttaca gcagccagat 2160 tttaggatt ttataagaca ttttaggag ttttatttc atcctgagag aaatgtgaag 2220 ccatcgaagg gttgaaag gagagtgagt tgatcagcat tgcattttag aaaaatccct 2280 ctatctgcaa cttgaaaaac attctggagg taagcaagcc tggaggccag gagcctagga 2340 gggctatttg atccagatga gaagtaatgg tgacctgaac tggggcag gcacctagga 2400 ttggaaaaca tggacagatc acaccactac ttatgtagta tactgtaa gacctggttg 2460 tttaaaagag aaggatgagg gaaagaggt CAaaacaac ttctaggact ctccattggc 2520 cagtgtggtg tgccctcac tgagagcaa acacaaatg aaagattgtg ggcaaggt 2580 tgagtcagtg agaagcaag gagagaacct tataaaaaaa tgactgt gattaaaaac 2640 ttaaaaattt ccccaacgt gtttatcttt tccattagca gaaataacta agagttgtct 2700 taattctaat gggatttatt ccatattgtc tctcatgccc tctacctagt tattagtgca 2760 atatttata tgtgcaca taaaactttt taactcttta ttctctctc tcgtgtaccc 2820 tcccagctct tggagggg tggattgag gcagatacca taagaaaag ttggtcacat 2880 ggtggtaaca cgttgaagtt atgccacatg agacatcagc actggcaaga gaatgtctg 2940 tgttgtagat gtttcacttg gagaaattg aaggaccctg agccttaaaa gtctgacaaa 3000 cttaagccag gaccctgtg gggaggtag aggggccac aaaacagatt gggagtcaga 3060 gagataacaa tgaatcccc aatgcctgtg ggaggtggac tccctggatt agtactagac 3120 agaaaaggta caaaatatt tcaaccatt ctcacactc tatatgtgtc tatgaccaga 3180 taactggaag accttctggt tatggactt gcgtacac tctcccagat agttagaggc 3240 atatctaaga ggttaacata tatgatctta tccaaaatgg gtctcttggt gctagtgttt 3300 tacatcagac ttcactggct ttcatgtatt tccacaagtg ccaaacattt ctcatatcct 3360 tgctgtattc catagagcag tgttcctgct acctggaaca cttgattctt gaataactcc 3420 tgtttacctt tcagacaaac cctaaaggtt accacctcaa agaagtcttt atagaagcct 3480 catcatctta gacactctgt attgtttcct tcatcgtatt tacaacagac agatactgtg 3540 cacttactgc ctcacttaac gacagggata cgttctgaaa ggtgcatcat taggcggttt 3600 tgttgtgtga acatcacaga gtgttactta cacaaaccta aatgatacag cctactaaac 3660 acctaggcta tatgagcaat acagcctatt gctcttaggc ttcaaacttg tacgacatgt 3720 cactgtactg aatactgtag gcaactataa cacagtggta agtatattgt gtatctaaac 3780 aaacatagaa aaggtaatgc actgtactat gatgttacaa cagctaggat gttgctatca 3840 atagaaattt ttcagcttca ttttattttt atgggaccac ctttgtatat gtggttcatt 3900 gttggccgaa acaccattct gtggcacatg actatgtatt tattcctcat tattccttta 3960 atattcatct cttccaggag ggcatgtcat ggacaatctc tttttcttac cacaggtctt 4020 aggacctggc ctagcacctg gccaagaact actggcatac ctccttttat tgtgcttcaa 4080 tttattgtgc tttgcaaata ctgaattttt tacaagttga agatttgtgg cacctctgta 4140 accagcaagt ctattggtgc cattttttca acatcatgtg cctgtttcct gtctcgctca 4200 tgtcacattt tggtaatttt cacaatatta aaaacttttt cattattatt a 4251

Claims

1. A composition for diagnosing SARS-CoV-2 coronavirus infection, the composition comprising (1) forward and reverse primers capable of specifically amplifying a SARS-CoV-2 precursor and a probe capable of complementary hybridization with the amplified SARS-CoV-2 precursor, and (2) forward and reverse primers capable of specifically amplifying an RNase P gene and a probe capable of complementary hybridization with the amplified RNase P gene, and The sequence of the forward primer capable of specifically amplifying the SARS-CoV-2 pre-converter is SEQ ID NO: 1, and the sequence of the reverse primer capable of specifically amplifying the SARS-CoV-2 pre-converter is SEQ ID NO:

2. The sequence of the probe capable of complementary hybridization with the amplified SARS-CoV-2 precursor is SEQ ID NO: 3; and The sequence of the forward primer that specifically amplifies the RNase P gene is SEQ ID NO: 7, the sequence of the reverse primer that specifically amplifies the RNase P gene is SEQ ID NO: 8, and the sequence of the probe that can hybridize complementaryly with the amplified RNase P gene is SEQ ID NO:

9.

2. A kit for diagnosing SARS-CoV-2 coronavirus infection, the kit comprising the composition according to claim 1.

3. The use of nucleic acid oligomers in the preparation of reagents for diagnosing SARS-CoV-2 coronavirus infection. The nucleic acid oligomer comprises (1) forward and reverse primers capable of specifically amplifying the SARS-CoV-2 precursor and a probe capable of complementary hybridization with the amplified SARS-CoV-2 precursor, and (2) forward and reverse primers capable of specifically amplifying the RNase P gene and a probe capable of complementary hybridization with the amplified RNase P gene; and The sequence of the forward primer capable of specifically amplifying the SARS-CoV-2 pre-converter is SEQ ID NO: 1, and the sequence of the reverse primer capable of specifically amplifying the SARS-CoV-2 pre-converter is SEQ ID NO:

2. The sequence of the probe capable of complementary hybridization with the amplified SARS-CoV-2 precursor is SEQ ID NO: 3; and The sequence of the forward primer that specifically amplifies the RNase P gene is SEQ ID NO: 7, the sequence of the reverse primer that specifically amplifies the RNase P gene is SEQ ID NO: 8, and the sequence of the probe that can hybridize complementaryly with the amplified RNase P gene is SEQ ID NO:

9.

4. The use according to claim 3, wherein the amplification is performed by RT-qPCR (quantitative reverse transcription PCR).